Boston Therapeutics, Inc.

Amendment
CIK: 0001473579·Pharmaceuticals·DELAWARE·Filed: Sep 20, 2016
Total Offering

$2,000,000

Amount Sold

$1,600,000

Investors

28

First Sale

Aug 12, 2016

Offering Details

Type
Debt, Option to Acquire, Security to be Acquired, Other: Convertible Promissory Notes and Warrants
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Carl W. Rausch
Related Person
Rom Eliaz
Related Person
Colin Neill
Related Person
Alan Hoberman
Related Person
Conroy Chi-Heng Cheng
Related Person

Company

Boston Therapeutics, Inc.

354 Merrimack Street, #4

Lawrence, MA, 01843

603-935-9799

SEC Filing

0001102624-16-003396

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Boston Therapeutics, Inc. Form D Filing — $2,000,000 | FilingFlow